Production (Stage)
CNS Pharmaceuticals, Inc.
CNSP
$0.811
$0.00370.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,500.54% | 1,077.58% | 666.70% | -65.14% | -84.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.83% | 54.12% | -66.33% | -64.44% | -57.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -89.85% | -- | -- | -- |
| Total Current Assets | 756.93% | 444.15% | 258.33% | -64.66% | -77.03% |
|
|
|||||
| Total Current Assets | 756.93% | 444.15% | 258.33% | -64.66% | -77.03% |
| Net Property, Plant & Equipment | 13.95% | 22.45% | -20.00% | 5.88% | -2.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -59.49% | -65.27% | -93.00% | -15.08% | -87.38% |
| Total Assets | 727.82% | 411.55% | 218.27% | -61.73% | -77.60% |
|
|
|||||
| Total Accounts Payable | -56.31% | -62.31% | -0.03% | 85.95% | 111.40% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -1.13% | 8.41% | -25.54% | -25.96% | -26.29% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -54.38% | -58.84% | -0.29% | 69.19% | 55.28% |
|
|
|||||
| Total Current Liabilities | -54.38% | -58.84% | -0.29% | 69.19% | 55.28% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -1.13% | 8.41% | -25.54% | -25.96% | -26.29% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -54.38% | -58.84% | -0.29% | 69.19% | 55.28% |
|
|
|||||
| Common Stock & APIC | 45.16% | 39.10% | 35.47% | 14.85% | 16.13% |
| Retained Earnings | -21.36% | -21.36% | -26.57% | -26.77% | -31.38% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 347.60% | 239.36% | 292.57% | -274.93% | -226.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 347.60% | 239.36% | 292.57% | -274.93% | -226.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 347.60% | 239.36% | 292.57% | -274.93% | -226.88% |
|
|
|||||